Spheroids are a powerful tool for in vitro tissue and disease modeling, with multiple applications across cancer and stem cell research and drug development.
In our new application note Spheroid biopirnting for disease modeling, we describe how Fluicell’s bioprinting platform Biopixlar lets you create spheroids to fit your research needs. With Biopixlar’s microfluidic high-precision cell deposition technology, you can control both the size and the cellular composition of the spheroids. Since you perform cell printing directly in culture media without any bioink, cell viability is high.
Learn more from our Lead Application Scientist Andreas Svanström, who provides comprehensive instructions how you can use Biopixlar to create spheroids in our Spheroid bioprinting for disease modeling application note.